Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep;29(5):330-4.
doi: 10.5001/omj.2014.89.

Effectiveness of topical curcumin for treatment of mastitis in breastfeeding women: a randomized, double-blind, placebo-controlled clinical trial

Raha Afshariani  1 , Pooya Farhadi  2 , Fariborz Ghaffarpasand  3 , Jamshid Roozbeh  4
Affiliations

Effectiveness of topical curcumin for treatment of mastitis in breastfeeding women: a randomized, double-blind, placebo-controlled clinical trial

Raha Afshariani et al. Oman Med J. 2014 Sep.

Abstract

Objective: To determine the efficacy of topical curcumin in reducing breast inflammation in women suffering from lactational mastitis.

Methods: A randomized double-blind, placebo-controlled study including 63 breastfeeding women with lactational mastitis were randomly assigned to receive curcumin topical cream, one pump every 8 hours for 3 days (n=32) or topical moisturizer as placebo (n=31). Using an index for severity of breast inflammation, all of the patients had moderate breast inflammation before entering the study. The outcome of treatment was evaluated using the same index at 24, 48 and 72 hours of starting the treatment.

Results: There was no significant difference between two study groups regarding the baseline characteristics such as age (p=0.361) and duration of lactation (p=0.551). After 72-hour of therapy, patients in curcumin groups had significantly lower rate of moderate (p=0.019) and mild (p=0.002) mastitis. Patients in curcumin group had significantly lower scores for tension (p<0.001), erythema (p<0.001) and pain (p<0.001), after 72-hour of treatment.

Conclusion: The results of the current study indicate that topical preparation of curcumin successfully decrease the markers of lactational mastitis such as pain, breast tension and erythema within 72 hours of administration without side effects. Thus, topical preparation of curcumin could be safely administered for those suffering from lactational mastitis after excluding infectious etiologies.

Keywords: Curcumin; Lactational Mastitis; Puerperal Mastitis; Turmeric.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CONSORT 2010 flow diagram for this randomized, double-blind, placebo-controlled clinical trial of effectiveness of topical curcumin for treatment of mastitis in breastfeeding women.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abou-Dakn M, Richardt A, Schaefer-Graf U, Wöckel A. Inflammatory Breast Diseases during Lactation: Milk Stasis, Puerperal Mastitis, Abscesses of the Breast, and Malignant Tumors - Current and Evidence-Based Strategies for Diagnosis and Therapy. Breast Care (Basel) 2010. Mar;5(1):33-37. 10.1159/000272223 - DOI - PMC - PubMed
    1. Jahanfar S, Ng CJ, Teng CL. Antibiotics for mastitis in breastfeeding women. Cochrane Database Syst Rev 2009;(1):CD005458. - PubMed
    1. Amin AL, Purdy AC, Mattingly JD, Kong AL, Termuhlen PM. Benign breast disease. Surg Clin North Am 2013. Apr;93(2):299-308. 10.1016/j.suc.2013.01.001 - DOI - PubMed
    1. Kasales CJ, Han B, Smith JS, Jr, Chetlen AL, Kaneda HJ, Shereef S. Nonpuerperal mastitis and subareolar abscess of the breast. AJR Am J Roentgenol 2014. Feb;202(2):W133-9. 10.2214/AJR.13.10551 - DOI - PubMed
    1. Kvist LJ. Toward a clarification of the concept of mastitis as used in empirical studies of breast inflammation during lactation. J Hum Lact 2010. Feb;26(1):53-59. 10.1177/0890334409349806 - DOI - PubMed

LinkOut - more resources